Lanzhou University Second Hospital
OrganisationROR
Trials
Collaborator, Phase 2, Not yet recruiting, 80 people, 4 Dec 2025
Collaborator, Phase 2, Status unknown, 31 people, 31 Jan 2022
Funded papers
17 Sept 2026
LCN2 promotes HEI-OC1 cells senescence via activating NF-κB signal pathway in presbycusis
CY2023-MS-A04, 14 Oct 2025
Sources: api.crossref.org